Development of Advanced Biomaterials

The summary for the Development of Advanced Biomaterials grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Development of Advanced Biomaterials: Biomaterials are fundamental to the design and development of a wide variety of medical devices and implants. In addition, ongoing advances in understanding cell biology, wound healing, and targeted drug effects are creating opportunities for the use of biomaterials in unprecedented ways. The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is in the process of building a scientific program to enhance the development of advanced biomaterials to meet the current and future needs for biomaterials in biology and medicine. The NIBIB seeks investigator-initiated applications for either NIH Research Project Grant (R01) awards or Exploratory/Developmental Research Grant (R21) awards for the development of novel biomaterials that can be used for a broad spectrum of biological and medical applications such as implantable medical devices, tissue engineering, drug and gene delivery, imaging agents, materials for minimally invasive surgery, and biosensors. The approach to biomaterials research should be mechanistic and in the context of fundamental engineering principles, design criteria, and strategies, including theory and modeling. The scope may cover the basic science and engineering aspects of biomaterials including their mechanical, physical, chemical, and biological properties, relevant design and production characteristics of devices constructed of these materials, and their clinical performance. Collaborative interdisciplinary research involving biomaterials scientists, materials scientists, biologists, physiologists, clinicians, engineers, and experts in any of the quantitative sciences is strongly encouraged. Innovative industrial partnerships are also welcome.